Calliditas Therapeutics AB (CALT)
40.00
0.00 (0.00%)
USD |
NASDAQ |
Sep 27, 16:00
Calliditas Therapeutics Total Liabilities (Quarterly): 154.56M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 154.56M |
| March 31, 2024 | 147.20M |
| December 31, 2023 | 151.43M |
| September 30, 2023 | 115.39M |
| June 30, 2023 | 110.94M |
| December 31, 2022 | 113.86M |
| September 30, 2022 | 71.13M |
| June 30, 2022 | 72.15M |
| March 31, 2022 | 51.24M |
| December 31, 2021 | 49.92M |
| September 30, 2021 | 54.38M |
| June 30, 2021 | 30.62M |
| March 31, 2021 | 29.20M |
| Date | Value |
|---|---|
| December 31, 2020 | 25.35M |
| September 30, 2020 | 7.071M |
| June 30, 2020 | 6.628M |
| March 31, 2020 | 5.957M |
| December 31, 2019 | 6.114M |
| September 30, 2019 | 3.156M |
| June 30, 2019 | 5.120M |
| March 31, 2019 | 3.184M |
| December 31, 2018 | 3.368M |
| September 30, 2018 | 3.181M |
| June 30, 2018 | 6.570M |
| March 31, 2018 | 3.848M |
| December 31, 2017 | 3.560M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
5.957M
Minimum
Mar 2020
154.56M
Maximum
Jun 2024
66.84M
Average
52.81M
Median
Total Liabilities (Quarterly) Benchmarks
| Abliva AB | 0.7797M |
| NuCana PLC | 20.58M |
| Karolinska Development AB | 1.264M |
| Oncopeptides AB | 14.80M |
| TC BioPharm (Holdings) PLC | 7.807M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 164.63M |
| Shareholders Equity (Quarterly) | 10.06M |
| Debt to Equity Ratio | 9.200 |
| Current Ratio | 2.686 |
| Net Debt Paydown Yield | -1.76% |